Position in BLLN
as of Mar 31, 2026
· filed Jul 17, 2026
Position Value
$17,369,562
+$7,362,741 QoQ
Shares Held
220,035
+80.0% QoQ
Ownership
0.478%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $3,145,181,729 across 32 Diagnostics & Research names. BLLN ranks #18 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,670,400 | $821,051,708 | |
| 2 | DHR |
Danaher Corp /De/
|
3,041,408 | $576,650,954 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,624,321 | $277,011,701 | |
| 4 | WAT |
Waters Corp /De/
|
695,644 | $207,162,780 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,109,387 | $191,369,256 | |
| 6 | DGX |
Quest Diagnostics Inc
|
807,477 | $158,249,338 | |
| 7 | ILMN |
Illumina, Inc.
|
1,155,973 | $142,485,227 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,204,289 | $137,264,856 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,369,562 | 220,035 | Shares | Defined | 2026-07-17 | |
| 2025-12-31 | $10,006,821 | 122,273 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||